A comprehensive review of immediate dissolving formulations: current state and future prospects
Abstract
Immediate Dissolving Formulations (IDFs) have emerged as a promising drug delivery system that addresses patient convenience and compliance issues associated with conventional dosage forms.This review aims to provide an in-depth analysis of IDFs, highlighting their formulation strategies, challenges, and recent developments.IDFs represent a novel approach to drug delivery, offering rapid and convenient administration of pharmaceutical compounds.This abstract provides an overview of the key characteristics and applications of IDFs.IDFs are innovative dosage forms designed to dissolve or disintegrate quickly upon contact with saliva or other aqueous media, releasing the active drug for absorption in the oral cavity.This rapid dissolution eliminates the need for swallowing, making IDFs particularly advantageous for patients with swallowing difficulties, pediatric populations, and individuals requiring fast onset
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.